| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 185.685.956 $ | +24.446.526 $ | +12,0 % | 10 | 163.149.231 $ | -87.361.977 $ | -28,3 % | 10 | 286.520.063 $ | +64.218.344 $ | +52,0 % | 11 | |||
| Nuvation Bio Inc. | NUVB | → 0 | Schwach | 45.900.586 $ | +11.232.714 $ | +32,4 % | 1 | 34.667.872 $ | -37.738.685 $ | -52,1 % | 1 | 72.406.557 $ | +39.731.528 $ | +121,6 % | 1 |
| Bicara Therapeutics Inc. | BCAX | → 0 | Neutral | 54.099.634 $ | +6.519.770 $ | +13,7 % | 1 | 47.579.864 $ | +10.475.604 $ | +28,2 % | 1 | 37.104.260 $ | +2.292.836 $ | +6,6 % | 1 |
| BridgeBio Oncology Therapeutics, Inc. | BBOT | → 0 | Neutral | 25.067.217 $ | -4.375.249 $ | -14,9 % | 1 | 29.442.466 $ | -11.744.090 $ | -28,5 % | 1 | 41.186.556 $ | +3.092.282 $ | +8,1 % | 1 |
| Beta Bionics, Inc. | BBNX | → 0 | Neutral | 20.624.588 $ | +7.436.434 $ | +56,4 % | 1 | 13.188.154 $ | -26.915.942 $ | -67,1 % | 1 | 40.104.096 $ | +1.951.212 $ | +5,1 % | 1 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. | KMTS | → 0 | Neutral | 26.003.471 $ | +5.632.041 $ | +27,6 % | 1 | 20.371.430 $ | -16.056.203 $ | -44,1 % | 1 | 36.427.633 $ | -2.678.785 $ | -6,8 % | 1 |
| Upstream Bio, Inc. | UPB | → 0 | Neutral | 36.008.855 $ | +10.496.984 $ | +41,1 % | 1 | ||||||||
| enGene Therapeutics Inc. | ENGN | → 0 | Schwach | 1.516.098 $ | -4.451.893 $ | -74,6 % | 1 | 5.967.991 $ | -1.945.513 $ | -24,6 % | 1 | 7.913.504 $ | +4.318.486 $ | +120,1 % | 1 |
| ALUMIS INC. | ALMS | → 0 | Sehr schwach | 6.788.916 $ | +1.474.068 $ | +27,7 % | 1 | 5.314.848 $ | -1.060.608 $ | -16,6 % | 1 | 6.375.456 $ | +3.769.096 $ | +144,6 % | 1 |
| Sana Biotechnology, Inc. | SANA | → 0 | Neutral | 2.944.688 $ | +514.688 $ | +21,2 % | 1 | 2.430.000 $ | -1.004.063 $ | -29,2 % | 1 | 3.434.063 $ | +438.750 $ | +14,6 % | 1 |
| ImageneBio, Inc. | IMA | → 0 | 2.686.630 $ | +409.825 $ | +18,0 % | 1 | 2.276.805 $ | -865.186 $ | -27,5 % | 1 | 3.141.991 $ | -569.201 $ | -15,3 % | 1 | |
| Replimune Group, Inc. | REPL | → 0 | Neutral | 1.909.801 $ | -507.291 $ | -21,0 % | 1 | 2.417.092 $ | +1.375.156 $ | +132,0 % | 1 | ||||
| Odyssey Therapeutics, Inc. | ODTX | → 0 | Neutral | 54.128 $ | +54.128 $ | 1 | |||||||||
| Gesamt | 185.685.956 $ | +24.446.526 $ | +12,0 % | 10 | 163.149.231 $ | -87.361.977 $ | -28,3 % | 10 | 286.520.063 $ | +64.218.344 $ | +52,0 % | 11 | |||